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background: The subcutaneous implantable cardioverter defibrillator (S-ICD) (Cameron Health/Boston Scientific) is approved to provide 
defibrillation therapy for the treatment of life-threatening ventricular tachyarrhythmias. The S-ICD has been found both safe and efficacious 
compared to traditional endovascular ICDs. Relative to traditional endovascular ICDs which have pulse generator (PG) sizes ranging from 30-40 ccs, 
the S-ICD has a significantly larger PG (70 ccs). While the studies have shown implant in patients across a range of body mass index (BMI), concern 
still exits regarding the size of the PG in patients with small body habitus. We report on our single center experience of S-ICD implants in patients 
with a BMI <25 kg/m2
methods: We evaluated out database of patients implanted with a S-ICD between 11/2012 and 11/2013 for patients with a BMI of 25 or less. 
Patient information was collected from our database and from inpatient and outpatient records.
results: Review of our database found 8 patients with a BMlless than 25 kg/m2. The mean age was 56±20 years old. 4 were male. 4 were 
implanted for primary prevention. 4 had a non-ischemic cardiomyopathy. The mean BMI of these selected patients was 21.1 ± 1.2 kg/m2 (18.7-
22.9). The mean height was 172 ± 12 cm (160-191). The mean weight was 63 ± 9.4 kgs (48-77). The mean left ventricular ejection fraction was 
34 ± 19 %. Successful defibrillation testing (OFT) was performed in 6 patients. OFT testing was not performed because of recent diagnosis of left 
ventricular thrombus, and inconsistent anticoagulation in a patient with chronic atrial fibrillation. There were no procedural complications. To date, 
there have been no incidences of pocket -infection or wound dehiscence.
conclusion: Despite a larger volume pulse generator, the S-ICD can be safely implanted in patients with BMI’s less than 25 kg/m2. This may make 
the S-ICD an appealing option for patients who have small body habitus or for pediatric patient populations.
